Edition:
India

Aslan Pharmaceuticals Files For U.S. IPO


Tuesday, 27 Mar 2018 

March 26 (Reuters) - Aslan Pharmaceuticals Ltd ::ASLAN PHARMACEUTICALS LIMITED FILES FOR U.S. IPO OF UP TO $86.3 MILLION – SEC FILING.ASLAN PHARMACEUTICALS LIMITED SAYS IT INTENDS TO APPLY TO HAVE ITS ADS LISTED ON NASDAQ GLOBAL MARKET UNDER THE SYMBOL "ASLN".ASLAN PHARMACEUTICALS LIMITED SAYS LEERINK PARTNERS, PIPER JAFFRAY ARE AMONG UNDERWRITERS TO IPO.ASLAN PHARMACEUTICALS LIMITED SAYS BTIG, H.C. WAINWRIGHT & CO, CLSA ARE AMONG UNDERWRITERS TO IPO.ASLAN PHARMACEUTICALS LIMITED SAYS PROPOSED IPO PRICE IS AN ESTIMATE SOLELY FOR CALCULATING SEC REGISTRATION FEE. 

Company Quote

4.5
 --
23 Apr 2019